HRT vs Testosterone Therapy in Perimenopause: What the Evidence Says
Standard HRT vs adding testosterone in perimenopause. Compare the evidence, benefits, who qualifies, and how prescribing works in the UK.
What Standard HRT Does in Perimenopause
Standard hormone replacement therapy for perimenopause typically combines oestradiol with a progestogen. Oestradiol addresses the most common and well-documented symptoms: hot flashes, night sweats, vaginal dryness, mood instability, and disrupted sleep. Progestogen is added to protect the uterine lining in women who still have a womb. The evidence base for oestrogen-based HRT is extensive, built over decades of clinical trials and observational studies. Most women who start oestradiol report measurable improvement in vasomotor symptoms within four to twelve weeks. Transdermal forms such as patches, gels, and sprays carry a lower risk of blood clots compared to oral oestrogen because they bypass first-pass liver metabolism. Body-identical oestradiol, derived from plant sources and chemically identical to the hormone produced by ovaries, is now widely available on the NHS and through private prescription. For many women, standard HRT alone resolves the majority of perimenopause symptoms and significantly improves quality of life without the need to add other hormones.
The Role of Testosterone in Female Hormonal Health
Testosterone is often thought of as a male hormone, but women produce it throughout their reproductive lives in the ovaries and adrenal glands. During perimenopause, testosterone levels decline alongside oestrogen and progesterone, and this decline can contribute to a specific cluster of symptoms that oestrogen alone may not fully address. Low testosterone in women is associated with reduced libido, persistent fatigue that does not respond to sleep improvements, low motivation, impaired concentration, and a blunted sense of wellbeing. Some women also report a reduction in muscle mass and bone density that occurs partly because of testosterone's anabolic effects. It is worth noting that the symptoms attributed to low testosterone significantly overlap with those caused by low oestrogen, which is why oestrogen deficiency should be corrected first before attributing residual symptoms to testosterone. Testing serum testosterone levels provides useful information but must be interpreted carefully because the assays used in most NHS laboratories are designed for male ranges and are less reliable at the lower concentrations typical in women.
Evidence for Adding Testosterone to HRT
The strongest and most consistent evidence for testosterone therapy in women relates to low sexual desire, specifically hypoactive sexual desire disorder. Multiple randomised controlled trials and a landmark 2019 systematic review published in The Lancet Diabetes and Endocrinology found that testosterone significantly improved sexual desire, arousal, orgasm, and satisfaction compared to placebo in postmenopausal women. The evidence in perimenopause is less extensive but aligns with the same biological rationale. Evidence for other symptoms, including cognitive function, fatigue, and mood, is promising but less robust and draws heavily on observational data and smaller trials. Some studies have shown improvements in muscle strength and bone mineral density with testosterone, which may be particularly relevant for women who are highly active or have concerns about osteoporosis. The British Menopause Society and National Institute for Health and Care Excellence both acknowledge testosterone as an option for women whose low libido does not respond adequately to oestrogen alone, provided prescribing is done within licensed clinical frameworks.
Who Benefits Most From Adding Testosterone
Not every woman in perimenopause needs or would benefit from testosterone. The clearest candidates are women who have already optimised their oestrogen and progesterone dose and still experience persistent low libido, flat mood, or profound fatigue that is disproportionate to their other symptoms. Women who have had a surgical menopause, where ovarian testosterone production stops abruptly rather than declining gradually, often experience more acute testosterone deficiency and may benefit sooner. Women with very active lifestyles or fitness goals may find testosterone supports muscle synthesis and recovery in ways that feel meaningful alongside their training. Conversely, women whose primary symptoms are vasomotor, such as hot flashes and night sweats, or those whose mood difficulties relate to progesterone intolerance or sleep disruption, are less likely to need testosterone as a first step. A careful symptom history, a trial of optimised HRT, and a blood test to confirm low levels are all appropriate steps before starting testosterone therapy.
Prescribing Testosterone in the UK: NHS vs Private
Testosterone therapy for women sits in a somewhat complicated prescribing landscape in the UK. The only testosterone product licensed for women is Intrinsa, a patch that was withdrawn from the UK market in 2012 for commercial reasons. As a result, any testosterone prescribed for women today is technically off-label, most commonly as Testogel, a gel licensed for men but used in women at a fraction of the dose, or as compounded testosterone cream from specialist pharmacies. The NHS does prescribe testosterone for women, and the 2021 NICE menopause guideline explicitly supports this, but access varies considerably by region and GP. Many women find it easier to access through a private menopause specialist or online menopause clinic, where practitioners are more familiar with off-label prescribing and monitoring protocols. Monitoring typically involves a follow-up blood test at three months to check total testosterone levels remain within the female physiological range and that no signs of virilisation, such as acne or unwanted hair growth, are present.
Choosing Between Standard HRT and Adding Testosterone
For most women in perimenopause, the practical approach is sequential rather than either-or. Start with oestradiol at an adequate dose alongside the appropriate progestogen, allow eight to twelve weeks for full effect, and then reassess remaining symptoms. If vasomotor symptoms, sleep, and mood have improved substantially but libido, drive, and energy remain significantly impaired, that is the appropriate time to discuss adding testosterone. Women who want to avoid hormonal therapy altogether may consider phytoestrogens, lifestyle adjustments, or non-hormonal prescription options, though none of these alternatives replicate the breadth of benefit that oestrogen provides. The decision to add testosterone should always involve a conversation about realistic expectations. Testosterone is not a stimulant and does not produce dramatic overnight changes. Most women who respond well notice gradual improvements in sexual interest and energy over six to twelve weeks. A cost comparison is also practical: standard HRT is inexpensive on NHS prescription while testosterone, often prescribed off-label, may require a private prescription that costs considerably more per month.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.